Activation of immune cells in bovine mammary gland secretions by zymosan-treated bovine serum

Journal of Dairy Science
Kayoko KimuraY Yokomizo

Abstract

Mastitis, caused by bacterial infection of the mammary gland, is a major disease of dairy cattle. The greatest risks of intramammary infection occur at the end of lactation and at the initiation of the next lactation when the cow calves. Treating serum with zymosan (yeast cell wall preparation) causes the complement to cleave, allowing this serum to serve as a source of complement fragment 5a (C5a), a potent chemoattractant and activator of the immune system. Our hypothesis was that intramammary infusion of zymosan-treated serum (ZTS) would recruit polymorphonuclear neutrophils (PMN) and generate prolonged activity in lymphocytes within the mammary gland. Ultimately this could help prevent bacterial infections in cows at dry-off and at the initiation of lactation. Two ipsilateral quarters of the mammary gland of each cow were infused with ZTS (12.5 mL/quarter), and 2 contralateral quarters were infused with saline in 8 cows shortly after lactation ended. Mammary secretions were collected periodically throughout the dry period and the first 2 wk of the next lactation. Activation status of lymphocytes and PMN in those secretions was assessed based on the intracellular presence or absence of IFN-gamma and IL-8 as determined by flo...Continue Reading

References

May 1, 1992·Zentralblatt für Veterinärmedizin. Reihe B. Journal of veterinary medicine. Series B·K PerssonA J Guidry
Jan 1, 1991·Veterinary Immunology and Immunopathology·A Bensaid, M Hadam
Feb 1, 1990·Clinical and Experimental Immunology·P A Campbell
Jun 1, 1989·Journal of Dairy Science·S C Nickerson
Jan 1, 1987·The International Journal of Biochemistry·L M SordilloS P Oliver
Feb 1, 1985·Journal of Dairy Science·K L SmithP S Schoenberger
Feb 1, 1982·Journal of Dairy Science·S P Oliver, K L Smith
Nov 1, 1982·Journal of Dairy Science·S P Oliver, K L Smith
Feb 1, 1980·The Journal of Dairy Research·C L CousinsF H Dodd
Apr 1, 1981·Veterinary Immunology and Immunopathology·J A Roth, M L Kaeberle
Sep 1, 1995·Proceedings of the Society for Experimental Biology and Medicine·P F TerranovaJ S Hunt
Jul 1, 1993·Veterinary Immunology and Immunopathology·K PerssonC Hallén Sandgren
Oct 1, 1995·Zentralblatt für Veterinärmedizin. Reihe B. Journal of veterinary medicine. Series B·J J RejmanS P Oliver
Jul 1, 1997·The Journal of Veterinary Medical Science·H OkadaT J Rosol
May 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J T UlrichS D Sanderson
May 16, 2000·Immunology·C H NielsenR G Leslie
Aug 26, 2000·Advances in Experimental Medicine and Biology·M J PaapeC Burvenich
Oct 25, 2000·Veterinary Immunology and Immunopathology·K HagiwaraH Iwai
Feb 2, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Niels C RiedemannPeter A Ward
Jun 1, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Niels C RiedemannPeter A Ward
Jul 5, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·K VenuprasadBhaskar Saha
Sep 17, 2003·The Journal of Experimental Medicine·Christoph W StreyJohn D Lambris
Mar 10, 2004·Reproduction, Nutrition, Development·Pascal Rainard, Céline Riollet
Apr 21, 2004·Immunology·Terri N Ellis, Blaine L Beaman

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.